Valuation Vext Science, Inc. BOERSE MUENCHEN
Stocks
VV5
CA9255401064
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1420 EUR | 0.00% |
|
-7.19% | -5.96% |
| 06-02 | Vext Science, Inc. Opens Sixth Dispensary in Fairfield Ohio | CI |
| 05-21 | Vext Science, Inc., Q1 2026 Earnings Call, May 21, 2026 |
Company Valuation: Vext Science, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 69.14 | 26.42 | 47.76 | 28.38 | 46.69 | 39.24 | - | - |
| Change | - | -61.79% | 80.79% | -40.58% | 64.53% | -15.96% | - | - |
| Enterprise Value (EV) 1 | 76.78 | 58.63 | 77.63 | 63.27 | 46.69 | 25.34 | 39.34 | 51.34 |
| Change | - | -23.63% | 32.4% | -18.51% | -26.21% | -45.73% | 55.26% | 30.51% |
| P/E | - | - | 7.07x | -1.43x | -2.66x | -16.1x | 16.1x | -16.1x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | 0x | 0.2x | 0.2x | -0x | 0x |
| Capitalization / Revenue | 1.86x | 0.75x | 1.37x | 0.79x | 0.91x | 0.73x | 0.57x | 0.53x |
| EV / Revenue | 2.06x | 1.66x | 2.23x | 1.76x | 0.91x | 0.47x | 0.57x | 0.69x |
| EV / EBITDA | 5.73x | 3.88x | 14x | 6.91x | - | 1.62x | 1.99x | 2.33x |
| EV / EBIT | - | - | -9.9x | -5.66x | - | 127x | 9.59x | - |
| EV / FCF | -10.8x | -20x | 46x | 34.7x | 5.73x | 2.69x | 2.22x | 2.62x |
| FCF Yield | -9.25% | -5.01% | 2.17% | 2.88% | 17.4% | 37.1% | 45.1% | 38.2% |
| Dividend per Share 3 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 3 | - | - | 0.041 | -0.115 | -0.0958 | -0.014 | 0.014 | -0.014 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 37.24 | 35.41 | 34.81 | 36 | 51.37 | 53.8 | 68.95 | 74 |
| EBITDA 1 | 13.39 | 15.12 | 5.528 | 9.153 | - | 15.6 | 19.8 | 22 |
| EBIT 1 | - | - | -7.843 | -11.18 | - | 0.2 | 4.1 | - |
| Net income 1 | - | - | - | - | -17.99 | -2.3 | 2.37 | -1.6 |
| Net Debt 1 | 7.635 | 32.22 | 29.88 | 34.89 | - | -13.9 | 0.1 | 12.1 |
| Reference price 3 | 0.6400 | 0.2400 | 0.2900 | 0.1650 | 0.2550 | 0.2250 | 0.2250 | 0.2250 |
| Nbr of stocks (in thousands) | 136,713 | 148,963 | 217,484 | 247,443 | 251,034 | 247,684 | - | - |
| Announcement Date | 20/04/22 | 22/03/23 | 10/05/24 | 31/03/25 | 29/04/26 | - | - | - |
1CAD in Million2USD in Million3CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 13.61x | 1.12x | 5.63x | - | 223M | |
| 11.15x | - | - | - | 144M | |
| 14.84x | - | - | - | 127M | |
| -1.19x | 0.66x | 2.9x | - | 95.4M | |
| -1.88x | 1.1x | 5.97x | - | 92.84M | |
| Average | 7.30x | 0.96x | 4.83x | 136.42M | ||
| Weighted average by Cap. | 9.14x | 1.01x | 5.07x |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VEXT Stock
- VV5 Stock
- Valuation Vext Science, Inc.
Select your edition
All financial news and data tailored to specific country editions
